Skip to main content

Table 1 Baseline demographics of patients

From: Patients’ and clinicians’ expectations on integrative medicine Services for Diabetes: a focus group study

Characteristics

Patient (n = 21)

Age group – no. (%)

41 to 60

3 (14.3)

61 or above

18 (85.7)

Male ratio – no. (%)

13 (61.9)

Education level – no. (%)

No formal education

1 (4.8)

Primary education

8 (38.1)

Secondary education

8 (38.1)

Tertiary education

4 (19.0)

Employment status – no. (%)

Part-time employed

1 (4.8)

Full-time employed

7 (33.3)

Unemployed or retired

13 (61.9)

History of diabetes – yrs

12 ± 5.6

Hemoglobin A1C – %

7.2 ± 0.7

Unsatisfactory control (7% or above) – no. (%)

15 (71.4)

Chronic kidney disease stage – no. (%)

Stage 2 (60 ml/min/1.73m2or above)

7 (33.3)

Stage 3a (45 to 59 ml/min/1.73m2)

5 (23.8)

Stage 3b (30 to 44 ml/min/1.73m2)

3 (14.3)

Stage 4 (15 to 29 ml/min/1.73m2)

5 (23.8)

Stage 5 (below 15 ml/min/1.73m2)

1 (4.8)

Urine albumin-to-creatinine ratio – no. (%)

< 3.4 mg/mmol (normo-albuminuria)

2 (9.5)

3.4 to 34 mg/mmol (micro-albuminuria)

10 (47.6)

> 34 mg/mmol (macro-albuminuria)

9 (42.9)

Comorbidity – no. (%)

Hypertension

21 (100)

Dyslipidemia

19 (90.5)

Diabetic retinopathy

6 (28.6)

Coronary artery disease

1 (4.8)

Major form of conventional medicine care received – no. (%)

Primary care

15 (71.4)

Secondary care

6 (28.6)

Chinese medicine service experience – no. (%)

Attended Chinese medicine consultation before

14 (66.7)

Encountered suspected Chinese medicine-related untoward events

2 (9.5)

Awareness of chronic kidney disease status – no. (%)

13 (61.9)

  1. In mean ± SD. Patients with end-stage kidney disease, macroalbuminuria, other co-morbidities and encountered suspected Chinese medicine-related untoward events were purposively sampled for the third-round interview